Skip to main content
FinSpry Logo
FinSpry
RIGL logo
RIGL
(NASDAQ)
Rigel Pharmaceuticals, Inc.
$45.89-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Rigel Pharmaceuticals (RIGL) Stock Price & Financial Analysis

Rigel Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$45.00 - $46.49
52-Week High$52.24
52-Week Low$24.95
Open$45.74
Volume322.08K
Average Volume (3M)312.00K
Market Cap903.39M
Shares Outstanding19.69M
P/E Ratio (TTM)2.29
Forward P/E1.10
Price to Sales (P/S)2.79
Price to Book (P/B)2.09
EV/EBITDA6.53
Revenue (TTM)299.77M
Net Income (TTM)364.23M
Free Cash Flow (TTM)79.27M
EPS (TTM)$19.21
Profit Margin121.51%
Operating Margin41.56%
Return on Equity (ROE)91.08%
Debt to Equity0.11
50-Day MA$38.06
200-Day MA$35.61
52-Week Change7.44%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Rigel Pharmaceuticals

What is the current stock price for RIGL?

As of the latest trading session, RIGL stock trades at $45.89. The 52-week range is $24.95–$52.24, with a day range of $45.00–$46.49.

What is the P/E ratio for RIGL?

Rigel Pharmaceuticals's trailing P/E ratio is 2.3, meaning investors pay $2.3 for every $1 of annual earnings. The forward P/E is 1.1, reflecting analyst expectations for future earnings. Rigel Pharmaceuticals operates in the Healthcare sector.

Does RIGL pay dividends?

Rigel Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RIGL?

Based on 1 analyst, the consensus for RIGL is Buy.

What is the market cap of RIGL?

Rigel Pharmaceuticals's market capitalization is $903.4M, classifying it as a small-cap company. Rigel Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.